Figure 4From: The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] Life-table plot of effects of simvastatin allocation on vascular and non-vascular death. See figure 2 for numbers of participants dying during follow-up.Back to article page
